Recombinant -synuclein and A1-40 activated the MAPkinase pathway in cells of hCMEC/D3 monolayers, so reducing expression of TJ proteins (Tai et al., 2010
Therapeutic effects in patient-derived osteosarcoma xenograft mouse model For a better understanding of the clinical potential, its therapeutic properties were assessed in a patient-derived osteosarcoma xenograft mouse model (PDX OS ) in immunodeficient nude mice (protocol for model establishment: Fig
S14FS14J)
Roaiah MF, Elkhayat YI, Abd El Salam MA, Din SFG

In humans, TB4 is present in high concentrations in all tissue types except red blood cells, with highest levels occurring in platelets, white blood cells, plasma, and wound fluid.17 TB4 is an important actin-binding protein that helps actin perform various functions, such as muscular contraction and maintaining proper cell shape, movement, and division.18 19 These effects on cells are why some experts suggest supplemental TB4 can improve the repair and recovery of muscle and other soft tissues,20 21 promote wound healing,22 reduce inflammation, and more.23 Researchers also note that TB4 is critical for the repair and regeneration of eye, heart, skin, nerve, and brain tissue after injury.4 The derivative TB-500 is based on one of the active sites of TB4, specifically the peptide segment responsible for the compounds actin-binding and cell migration abilities.4 Since most of TB4s potential benefits are attributed to its actin-binding properties, it can be assumed that the same applies to TB-500

The duration of each IV treatment can vary depending on the specific treatment plan and type